Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
OtherPerspective
Open Access

Targeting the lysine lactylome for the treatment of glioma

Di Wang, Guanzhang Li, Tao Jiang and Wei Zhang
Cancer Biology & Medicine December 2024, 20240461; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0461
Di Wang
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
2Clinical Center for Glioma, Capital Medical University, Beijing 100070, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guanzhang Li
2Clinical Center for Glioma, Capital Medical University, Beijing 100070, China
3Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
4Beijing Engineering Research Center of Targeted Drugs and Cell Therapy for CNS Tumors, Beijing 102600, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Jiang
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
2Clinical Center for Glioma, Capital Medical University, Beijing 100070, China
3Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
4Beijing Engineering Research Center of Targeted Drugs and Cell Therapy for CNS Tumors, Beijing 102600, China
5Brain Tumor Center, Beijing Institute of Brain Disorders, Beijing 100069, China
6China National Clinical Research Center for Neurological Diseases, Beijing 100070, China
7National Center for Neurological Disorders, Beijing 100070, China
8Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA), Beijing 100070, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tao Jiang
  • For correspondence: taojiang1964{at}163.com zhangwei_vincent{at}mail.ccmu.edu.cn
Wei Zhang
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
2Clinical Center for Glioma, Capital Medical University, Beijing 100070, China
3Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
4Beijing Engineering Research Center of Targeted Drugs and Cell Therapy for CNS Tumors, Beijing 102600, China
5Brain Tumor Center, Beijing Institute of Brain Disorders, Beijing 100069, China
6China National Clinical Research Center for Neurological Diseases, Beijing 100070, China
7National Center for Neurological Disorders, Beijing 100070, China
8Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA), Beijing 100070, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wei Zhang
  • For correspondence: taojiang1964{at}163.com zhangwei_vincent{at}mail.ccmu.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

20240461
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2024.0461

Published By 
Cancer Biology & Medicine
History 
  • Received October 29, 2024
  • Accepted December 9, 2024
  • Published online December 30, 2024.

Article Versions

  • You are currently viewing a previous version of this article (December 30, 2024 - 02:39).
  • View the most recent version of this article
Copyright & Usage 
Copyright: © 2024, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

Funding

  • National Natural Science Foundation of China

    82072768
  • Youth Beijing Scholar

    055
  • The Outstanding Young Scientist Program of Beijing Universities

    JWZQ20240101026
  • Beijing Municipal Health Commission Research Ward Excellence Clinical Research Program

    BRWEP2024W032040200

This work was supported by the National Natural Science Foundation of China (Grant No. 82072768), Youth Beijing Scholar (Grant No. 055), The Outstanding Young Scientist Program of Beijing Universities (Grant No. JWZQ20240101026), and Beijing Municipal Health Commission Research Ward Excellence Clinical Research Program (Grant No. BRWEP2024W032040200).

Next
Back to top

In this issue

Cancer Biology & Medicine: 22 (12)
Cancer Biology & Medicine
Vol. 22, Issue 12
15 Dec 2025
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Targeting the lysine lactylome for the treatment of glioma
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Targeting the lysine lactylome for the treatment of glioma
Di Wang, Guanzhang Li, Tao Jiang, Wei Zhang
Cancer Biology & Medicine Dec 2024, 20240461; DOI: 10.20892/j.issn.2095-3941.2024.0461

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Targeting the lysine lactylome for the treatment of glioma
Di Wang, Guanzhang Li, Tao Jiang, Wei Zhang
Cancer Biology & Medicine Dec 2024, 20240461; DOI: 10.20892/j.issn.2095-3941.2024.0461
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Histone lactylation and glioma
    • Non-histone lactylation and glioma
    • Targeting the lysine L-lactylome to improve outcomes of patients with glioma
    • Future perspectives
    • Conflict of interest statement
    • Author contributions
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • From bone marrow to the tumor microenvironment: how neutrophil maturation shapes cancer immunity
  • Immunological and metabolic optimization of tumor neoantigen vaccines
  • Chromatin relaxation dynamics and histone PTMs in the early DNA damage response
Show more Perspective

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire